Knowledge Center

Article / May 08, 2026

Overcoming Dose Limitations in Pulmonary Delivery

Authors:
  • Rui Churro
Source:
Hovione Expert Insights

Drug administration via the lungs dates back to antiquity, evolving from ancient rituals and herbal remedies to the rise of modern pharmacology. 

Despite this, drug delivery to the lungs is still one of the most sophisticated frontiers in medicine, leveraging a deeper understanding of the biology of respiratory diseases, airway structures, and aerosol transport and deposition.

Read the full article

 

 

Related links

Read the full article here

Also in the Knowledge Center

Related Content

Dispersome™

Make your drug soluble with Dispersome™ technology. Dispersome is a solubility enhancement technology that relies on an innovative and naturally occurring excipient to develop amorphous solid dispersions with high drug loading and high bioavailability.

Page
Read more

Drug Product Development

Leveraging our expertise particle engineering, Hovione can now develop oral dosage forms and inhaled dosages forms to offer dependable solutions for complex drug products.

Page
Read more

Continuous Tableting for Drug Product

Hovione´s pragmatic approach to bridging science with manufacturing is now being leveraged for continuous tableting and it is the key to ultimately providing high quality medicines and the success of your drug product.

Page
Read more